The Workup of the Abnormal CBC in the Molecular Era
Description: Dan Jones, MD, PhD, Medical Director for Hematopathology and Cancer Diagnostics at the Quest Diagnostics Nichols Institute in Chantilly, VA, discusses algorithms and recommendations for additional testing to diagnose benign and neoplastic hematologic conditions in blood upon finding abnormal CBC results.
Learning objectives — at the conclusion of this program participants will be able to:
• Discuss the use of flow cytometry as a triage tool for lymphoid and myeloid processes
• Describe the use of BCR-ABL1 and JAK2 quantitative assays to diagnose and monitor myeloproliferative neoplasms
• Assess the contribution of genomic arrays to diagnosing myelodysplastic syndromes at the earlier stages
• Communicate the use of advanced sequencing mutation assays in the diagnosis and follow-up of myeloid neoplasms